CD36 polymorphism and its relationship with body mass index and coronary artery disease in a Korean population

Clinical Chemistry and Laboratory Medicine

Volumn 45, Issue 10, 2007, Pages 1277-1282

  Min Yun, Yeo ^a   Young Song, Eun ^a   Hoon Song, Sang ^c   Song, Junghan ^b,c   Kim, Jin Q ^c  

^a Konkuk University School of Medicine   (South Korea)

^b Seoul National University Bundang Hospital   (South Korea)

^c Seoul National University   (South Korea)

Author keywords

Body mass index; CD36; Coronary artery disease; Obesity; Polymorphisms

Indexed keywords

CD36 ANTIGEN;

ADULT; AGE DISTRIBUTION; AMINO ACID SUBSTITUTION; ANALYSIS OF COVARIANCE; ARTICLE; BODY MASS; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY RISK; CORRELATION ANALYSIS; FEMALE; FREQUENCY ANALYSIS; GENE FREQUENCY; GENE MUTATION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENOTYPE; HETEROZYGOTE; HOMOZYGOSITY; HUMAN; HYPERTENSION; INTRON; KOREA; LIPID ANALYSIS; MAJOR CLINICAL STUDY; MALE; POLYACRYLAMIDE GEL ELECTROPHORESIS; POLYMERASE CHAIN REACTION; POPULATION RESEARCH; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK FACTOR; SMOKING; STATISTICAL SIGNIFICANCE;

AGE FACTORS; AGED; ANTIGENS, CD36; BODY MASS INDEX; CASE-CONTROL STUDIES; CORONARY ARTERY DISEASE; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FEMALE; GENOTYPE; HUMANS; HYPERTENSION; KOREA; LIPIDS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POPULATION GROUPS; RISK FACTORS; SMOKING;

EID: 35048812934     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/CCLM.2007.270     Document Type: Article

References (32)

1. Talle MA, Rao PE, Westberg E, Allegar N, Makowski M, Mittler RS, et al. Patterns of antigenic expression on human monocytes as defined by monoclonal antibodies. Cell Immunol 1983;78:83-99.
2. Swerlick RA, Lee KH, Wick TM, Lawley TJ. Human dermal microvascular endothelial but not human umbilical vein endothelial cells express CD36 in vivo and in vitro. J Immunol 1992;148:78-83.
3. Endemann G, Stanton LW, Madden KS, Bryant CM, White RT, Protter AA. CD36 is a receptor for oxidized low-density lipoprotein. J Biol Chem 1993;268:11811-6.
4. Brouwers A, Langlois M, Delanghe J, Billiet J, De Buyzere M, Vercaemst R, et al. Oxidized low-density lipoprotein, iron stores, and haptoglobin polymorphism. Atherosclerosis 2004;176:189-95.
5. Asch AS, Silbiger S, Heimer E, Nachman RL. Thrombospondin sequence motif (CSVTCG) is responsible for CD36 binding. Biochem Biophys Res Commun 1992;182:1208-17.
6. Barnwell JW, Ockenhouse CF, Knowles DM II. Monoclonal antibody OKM5 inhibits the in vitro binding of Plasmodium falciparum-infected erythrocytes to monocytes, endothelial, and C32 melanoma cells. J Immunol 1985;135:3494-7.
7. Abumrad NA, el-Maghrabi MR, Amri EZ, Lopez E, Grimaldi PA. Cloning of a rat adipocyte membrane protein implicated in binding or transport of long-chain fatty acids that is induced during preadipocyte differentiation. Homology with human CD36. J Biol Chem 1993;268:17665-8.
8. Hoebe K, Georgel P, Rutschmann S, Du X, Mudd S, Crozat K, et al. CD36 is a sensor of diacylglycerides. Nature 2005;433:523-7.
9. Aitman TJ, Glazier AM, Wallace CA, Cooper LD, Norsworthy PJ, Wahid FN, et al. Identification of Cd36 (Fat) as an insulin-resistance gene causing defective fatty acid and glucose metabolism in hypertensive rats. Nat Genet 1999;21:76-83.
10. Glazier AM, Scott J, Aitman TJ. Molecular basis of the Cd36 chromosomal deletion underlying SHR defects in insulin action and fatty acid metabolism. Mamm Genome 2002;13:108-13.
11. Pravenec M, Landa V, Zidek V, Musilova A, Kren V, Kazdova L, et al. Transgenic rescue of defective Cd36 ameliorates insulin resistance in spontaneously hypertensive rats. Nat Genet 2001;27:156-8.
12. Hajri T, Ibrahimi A, Coburn CT, Knapp FF Jr, Kurtz T, Pravenec M, et al. Defective fatty acid uptake in the spontaneously hypertensive rat is a primary determinant of altered glucose metabolism, hyperinsulinemia, and myocardial hypertrophy. J Biol Chem 2001;276:23661-6.
13. Fernandez-Ruiz E, Armesilla AL, Sanchez-Madrid F, Vega MA. Gene encoding the collagen type I and thrombospondin receptor CD36 is located on chromosome 7q11.2. Genomics 1993;17:759-61.
14. Armesilla AL, Vega MA. Structural organization of the gene for human CD36 glycoprotein. J Biol Chem 1994;269:18985-91.
15. Kashiwagi H, Honda S, Tomiyama Y, Mizutani H, Take H, Honda Y, et al. A novel polymorphism in glycoprotein IV (replacement of proline-90 by serine) predominates in subjects with platelet GPIV deficiency. Thromb Haemost 1993;69:481-4.
16. Kashiwagi H, Tomiyama Y, Nozaki S, Kiyoi T, Tadokoro S, Matsumoto K, et al. Analyses of genetic abnormalities in type I CD36 deficiency in Japan: identification and cell biological characterization of two novel mutations that cause CD36 deficiency in man. Hum Genet 2001;108:459-66.
17. Miyaoka K, Kuwasako T, Hirano K, Nozaki S, Yamashita S, Matsuzawa Y. CD36 deficiency associated with insulin resistance. Lancet 2001;357:686-7.
18. Aitman TJ, Cooper LD, Norsworthy PJ, Wahid FN, Gray JK, Curtis BR, et al. Malaria susceptibility and CD36 mutation. Nature 2000;405:1015-6.
19. Omi K, Ohashi J, Patarapotikul J, Hananantachai H, Naka I, Looareesuwan S, et al. CD36 polymorphism is associated with protection from cerebral malaria. Am J Hum Genet 2003;72:364-74.
20. Friedewald WT, Levy RI, Fredrikson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972;18:499-502.
21. Kajihara S, Hisatomi A, Ogawa Y, Yasutake T, Yoshimura T, Hara T, et al. Association of the Pro90Ser CD36 mutation with elevated free fatty acid concentrations but not with insulin resistance syndrome in Japanese. Clin Chim Acta 2001;314:125-30.
22. Smalley KJ, Knerr AN, Kendrick ZV, Colliver JA, Owen OE. Reassessment of body mass indices. Am J Clin Nutr 1990;52:405-8.
23. Blair D, Habicht JP, Sims EA, Sylwester D, Abraham S. Evidence for an increased risk for hypertension with cen trally located body fat and the effect of race and sex on this risk. Am J Epidemiol 1984;119:526-40.
24. Webb T, Whittington J, Holland AJ, Soni S, Boer H, Clarke D, et al. CD36 expression and its relationship with obesity in blood cells from people with and without Prader-Willi syndrome. Clin Genet 2006;69:26-32.
25. Nozaki S, Tanaka T, Yamashita S, Sohmiya K, Yoshizumi T, Okamoto F, et al. CD36 mediates long-chain fatty acid transport in human myocardium: complete myocardial accumulation defect of radiolabeled long-chain fatty acid analog in subjects with CD36 deficiency. Mol Cell Biochem 1999;192:129-35.
26. Tanaka T, Sohmiya K, Kawamura K. Is CD36 deficiency an etiology of hereditary hypertrophic cardiomyopathy? J Mol Cell Cardiol 1997;29:121-7.
27. Yoshizumi T, Nozaki S, Fukuchi K, Yamasaki K, Fukuchi T, Maruyama T, et al. Pharmacokinetics and metabolism of 123I-BMIPP fatty acid analog in healthy and CD36-deficient subjects. J Nucl Med 2000;41:1134-8.
28. Bonen A, Tandon NN, Glatz JF, Luiken JJ, Heigenhauser GJ. The fatty acid transporter FAT/CD36 is upregulated in subcutaneous and visceral adipose tissues in human obesity and type 2 diabetes. Int J Obes (Lond) 2006;30:877-83.
29. Kashiwagi H, Tomiyama Y, Honda S, Kosugi S, Shiraga M, Nagao N, et al. Molecular basis of CD36 deficiency: evidence that a 478-C-to-T substitution (proline90-to-serine) in CD36 cDNA accounts for CD36 deficiency. J Clin Invest 1995;95:1040-6.
30. Urwijitaroon Y, Barusrux S, Romphruk A, Puapairoj C. Frequency of human platelet antigens among blood donors in northeastern Thailand. Transfusion 1995;35:868-70.
31. Curtis BR, Aster RH. Incidence of the Nak(a)-negative platelet phenotype in African Americans is similar to that of Asians. Transfusion 1996;36:331-4.
32. Yamamoto N, Akamatsu N, Sakuraba H, Yamazaki H, Tanoue K. Platelet glycoprotein IV (CD36) deficiency is associated with the absence (type I) or the presence (type II) of glycoprotein IV on monocytes. Blood 1994;83:392-7.